<DOC>
	<DOCNO>NCT02607176</DOCNO>
	<brief_summary>The objective study evaluate safety efficacy Heweizhixie Capsule patient diarrhea .</brief_summary>
	<brief_title>Heweizhixie capsuleTherapy Patients With Diarrhea</brief_title>
	<detailed_description>The objective study evaluate safety efficacy Heweizhixie Capsule patient diarrhea.This Phase 4 Open Label trial , enroll 2400 patient diarrhea Primary Outcome Measure : Percent subject treatment Success Secondary Outcome Measures : Number unformed stool pass per 24 h period Time ( hour ) first intake last unformed stool Change baseline Leeds dyspepsia questionnaire score Percent subject AE .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<criteria>3 unformed stool 24 hour Male female subject 18 80 year old Signed informed consent Subjects serum ALT 5ULN serum Cr 442umol/L Subjects pregnant , likely become pregnant Subjects , opinion Investigator , suitable candidate enrollment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>